source
- Federal judge halts Colorado price cap on Amgen's Enbrel drugA U.S. district judge issued an injunction that stops the Colorado Prescription Drug Affordability Board from imposing a payment limit on Enbrel, a high-volume biologic sold by Amgen. The court fou…
- BrightGene advances obesity drug toward Chinese approval, eyes Western data and partnersBrightGene has submitted its obesity GLP-1 candidate to Chinese regulators after reporting strong Phase 3 results. The company says data from Western trials are expected to be even more robust, wh…